Selected research
Industry Growth & Trends
Global Rheolytic Thrombectomy Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Rheolytic Thrombectomy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Rheolytic Thrombectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Rheolytic Thrombectomy market include Abbott Laboratories, Koninklijke Philips N.V., Terumo Corporation, Boston Scientific Group, Medtronic plc, AngioDynamics, Penumbra Inc., Stryker Corporation and Teleflex Incorporated, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Rheolytic Thrombectomy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Rheolytic Thrombectomy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rheolytic Thrombectomy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rheolytic Thrombectomy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Rheolytic Thrombectomy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Rheolytic Thrombectomy Market by Company
Abbott Laboratories
Koninklijke Philips N.V.
Terumo Corporation
Boston Scientific Group
Medtronic plc
AngioDynamics
Penumbra Inc.
Stryker Corporation
Teleflex Incorporated
Johnson and Johnson
Rheolytic Thrombectomy Segment by Type
Automated Devices
Manual Devices
Rheolytic Thrombectomy Segment by Application
Peripheral Diseases
Coronary Disease
Neural Diseases
Rheolytic Thrombectomy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheolytic Thrombectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rheolytic Thrombectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheolytic Thrombectomy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Rheolytic Thrombectomy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Automated Devices
- Manual Devices
Applications
- Peripheral Diseases
- Coronary Disease
- Neural Diseases
Companies covered
- Abbott Laboratories
- Koninklijke Philips N.V.
- Terumo Corporation
- Boston Scientific Group
- Medtronic plc
- AngioDynamics
- Penumbra Inc.
- Stryker Corporation
- Teleflex Incorporated
- Johnson and Johnson
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Rheolytic Thrombectomy Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Rheolytic Thrombectomy Market Size by Region (2021-2032)
- 1.4.1 Global Rheolytic Thrombectomy Market Size by Region (2021-2026)
- 1.4.2 Global Rheolytic Thrombectomy Market Size by Region (2027-2032)
- 1.5 Key Regions Rheolytic Thrombectomy Market Size (2021-2032)
- 1.5.1 North America Rheolytic Thrombectomy Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Rheolytic Thrombectomy Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Rheolytic Thrombectomy Market Size Growth Rate (2021-2032)
- 1.5.4 South America Rheolytic Thrombectomy Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Rheolytic Thrombectomy Market Size Growth Rate (2021-2032)
2 Rheolytic Thrombectomy Market by Type
- 2.1 Type Introduction
- 2.1.1 Automated Devices
- 2.1.2 Manual Devices
- 2.2 Global Rheolytic Thrombectomy Market Size by Type
- 2.2.1 Global Rheolytic Thrombectomy Market Size Overview by Type (2021-2032)
- 2.2.2 Global Rheolytic Thrombectomy Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Rheolytic Thrombectomy Market Size Forecasted by Type (2027-2032)
- 2.3 Global Rheolytic Thrombectomy Market Size by Regions
- 2.3.1 North America Rheolytic Thrombectomy Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Rheolytic Thrombectomy Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Rheolytic Thrombectomy Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Rheolytic Thrombectomy Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Rheolytic Thrombectomy Market Size Breakdown by Type (2021-2026)
3 Rheolytic Thrombectomy Market by Application
- 3.1 Type Introduction
- 3.1.1 Peripheral Diseases
- 3.1.2 Coronary Disease
- 3.1.3 Neural Diseases
- 3.2 Global Rheolytic Thrombectomy Market Size by Application
- 3.2.1 Global Rheolytic Thrombectomy Market Size Overview by Application (2021-2032)
- 3.2.2 Global Rheolytic Thrombectomy Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Rheolytic Thrombectomy Market Size Forecasted by Application (2027-2032)
- 3.3 Global Rheolytic Thrombectomy Market Size by Regions
- 3.3.1 North America Rheolytic Thrombectomy Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Rheolytic Thrombectomy Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Rheolytic Thrombectomy Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Rheolytic Thrombectomy Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Rheolytic Thrombectomy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Rheolytic Thrombectomy Industry Trends
- 4.2 Rheolytic Thrombectomy Industry Drivers
- 4.3 Rheolytic Thrombectomy Industry Opportunities and Challenges
- 4.4 Rheolytic Thrombectomy Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Rheolytic Thrombectomy Revenue (2021-2026)
- 5.2 Global Rheolytic Thrombectomy Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Rheolytic Thrombectomy Key Company Headquarters & Area Served
- 5.4 Global Rheolytic Thrombectomy Company, Product Type & Application
- 5.5 Global Rheolytic Thrombectomy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Rheolytic Thrombectomy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Rheolytic Thrombectomy Players Market Share by Revenue in 2025
- 5.6.3 2025 Rheolytic Thrombectomy Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Abbott Laboratories
- 6.1.1 Abbott Laboratories Company Information
- 6.1.2 Abbott Laboratories Business Overview
- 6.1.3 Abbott Laboratories Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Abbott Laboratories Rheolytic Thrombectomy Product Portfolio
- 6.1.5 Abbott Laboratories Recent Developments
- 6.2 Koninklijke Philips N.V.
- 6.2.1 Koninklijke Philips N.V. Company Information
- 6.2.2 Koninklijke Philips N.V. Business Overview
- 6.2.3 Koninklijke Philips N.V. Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Koninklijke Philips N.V. Rheolytic Thrombectomy Product Portfolio
- 6.2.5 Koninklijke Philips N.V. Recent Developments
- 6.3 Terumo Corporation
- 6.3.1 Terumo Corporation Company Information
- 6.3.2 Terumo Corporation Business Overview
- 6.3.3 Terumo Corporation Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Terumo Corporation Rheolytic Thrombectomy Product Portfolio
- 6.3.5 Terumo Corporation Recent Developments
- 6.4 Boston Scientific Group
- 6.4.1 Boston Scientific Group Company Information
- 6.4.2 Boston Scientific Group Business Overview
- 6.4.3 Boston Scientific Group Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Boston Scientific Group Rheolytic Thrombectomy Product Portfolio
- 6.4.5 Boston Scientific Group Recent Developments
- 6.5 Medtronic plc
- 6.5.1 Medtronic plc Company Information
- 6.5.2 Medtronic plc Business Overview
- 6.5.3 Medtronic plc Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Medtronic plc Rheolytic Thrombectomy Product Portfolio
- 6.5.5 Medtronic plc Recent Developments
- 6.6 AngioDynamics
- 6.6.1 AngioDynamics Company Information
- 6.6.2 AngioDynamics Business Overview
- 6.6.3 AngioDynamics Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 AngioDynamics Rheolytic Thrombectomy Product Portfolio
- 6.6.5 AngioDynamics Recent Developments
- 6.7 Penumbra Inc.
- 6.7.1 Penumbra Inc. Company Information
- 6.7.2 Penumbra Inc. Business Overview
- 6.7.3 Penumbra Inc. Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Penumbra Inc. Rheolytic Thrombectomy Product Portfolio
- 6.7.5 Penumbra Inc. Recent Developments
- 6.8 Stryker Corporation
- 6.8.1 Stryker Corporation Company Information
- 6.8.2 Stryker Corporation Business Overview
- 6.8.3 Stryker Corporation Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Stryker Corporation Rheolytic Thrombectomy Product Portfolio
- 6.8.5 Stryker Corporation Recent Developments
- 6.9 Teleflex Incorporated
- 6.9.1 Teleflex Incorporated Company Information
- 6.9.2 Teleflex Incorporated Business Overview
- 6.9.3 Teleflex Incorporated Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Teleflex Incorporated Rheolytic Thrombectomy Product Portfolio
- 6.9.5 Teleflex Incorporated Recent Developments
- 6.10 Johnson and Johnson
- 6.10.1 Johnson and Johnson Company Information
- 6.10.2 Johnson and Johnson Business Overview
- 6.10.3 Johnson and Johnson Rheolytic Thrombectomy Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Johnson and Johnson Rheolytic Thrombectomy Product Portfolio
- 6.10.5 Johnson and Johnson Recent Developments
7 North America
- 7.1 North America Rheolytic Thrombectomy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 7.3 North America Rheolytic Thrombectomy Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Rheolytic Thrombectomy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 8.3 Europe Rheolytic Thrombectomy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Rheolytic Thrombectomy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Rheolytic Thrombectomy Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Rheolytic Thrombectomy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 10.3 South America Rheolytic Thrombectomy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Rheolytic Thrombectomy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Rheolytic Thrombectomy Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Rheolytic Thrombectomy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst